Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Decitabine in Patients with Myelodysplastic Syndromes: A Multi-Center, Open-Label, Dose Comparison Trial

Hui Liu,Hao Jiang,Hongyan Tong,Ruixiang Xia,Linhua Yang,Hongguo Zhao,Jian Ouyang,Hai Bai,Hui Sun,Li Hou,Ming Jiang,Yun Zeng,Zhuogang Liu,Aibin Liang,Yinghua Xie,Kang Yu,Zhimin Zhai,Li Liu,Jinsong Jia,Rong Fu,Zonghong Shao

CANCER MEDICINE（2023）

Cited 2|Views63
Key words
complete remission,decitabine,hypomethylating agent,myelodysplastic syndromes,overall survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined